Microbial Services: Protein Manufacturing

Microbial manufacturing services offer a fast and efficient pathway for producing therapeutic proteins using expression systems such as E. coli and P. pastoris. These platforms support the full development lifecycle, including strain engineering, master cell bank generation, analytical transfer, process development, scale‑up, engineering runs, and GMP manufacturing. Fermentation capabilities range from small volumes to 2000 L, enabling flexibility from early research quantities to large‑scale clinical production. Downstream processing is supported by robust purification workflows, auxiliary equipment, and in‑house quality control with more than 90 qualified analytical methods. IP‑free molecular biology toolkits allow customization of expression strategies without licensing constraints.

Fast timelines—often delivering GMP material in roughly 12 months—help reduce delays and accelerate project progression. Integrated fill‑finish partnerships further minimize tech‑transfer risks and maintain continuity from upstream development to final drug product manufacturing. Overall, these microbial services provide a scalable, cost‑effective, and streamlined route from gene to clinical‑ready material.